Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |